Trendlines Medical Singapore Pte. Ltd. is a new medical technology start-up incubator established in 2016 by The Trendlines Group and B. Braun, one of the world’s leading global medical device players. Read the announcement.
Trendlines Medical Singapore operates similarly to Trendlines Medical (Israel) and it discovers, invests in, incubates and provides a range of services to nurture and develop Singapore-based entrepreneurs and start-up companies involved in novel medical devices and technologies with a view toward success in the global market. Trendlines Medical Singapore and its shareholders believe that Singapore’s strong scientific base, supported by internationally acclaimed universities and research institutes and an excellent infrastructure of hospitals and healthcare providers create opportunities to develop successful medical technology companies. The primary sources for innovative technologies will therefore be from Singapore universities, research institutes, hospitals, and entrepreneurs. Trendlines Medical Singapore may also start companies that fully operate from Singapore but are based on technologies that are not necessarily originated in Singapore – including (possibly) technologies developed by Trendlines Labs, which is Trendlines’ in-house innovation center.
Like the Trendlines Group, Trendlines Medical Singapore is an “intense” investor. From the time of its initial investment, it is intensely involved in the portfolio companies by supporting technology development, business development, market and commercialization strategies, funding strategy, finance, and marketing communications.
Are you a passionate entrepreneur with an idea for an exciting new medical product or technology? Or are you interested in investment opportunities? We’d like to hear from you.
Contact Trendlines Medical Singapore CEO Eric Loh.